US 11613544
Substituted imidazo[1,5-a]pyrazines for modulation of IRE1
granted A61PA61P1/16A61P11/00
Quick answer
US patent 11613544 (Substituted imidazo[1,5-a]pyrazines for modulation of IRE1) held by The Regents of the University of California expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P1/16, A61P11/00, A61P21/00, A61P25/00